EUVIMEDEUVIMED entdecken
Crossref

Development of Benzimidazole‐Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies

Akash P Sakla, Mohd Rabi Bazaz, Ashutosh Mahale, Pravesh Sharma, Durgesh Gurukkala Valapil, Onkar Prakash Kulkarni, Manoj P Dandekar, Nagula Shankaraiah iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Akash P Sakla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Hyderabad, 500037, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Apoptosis, Benzimidazoles, Cell Proliferation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of spirocyclopropyl oxindoles with benzimidazole substitutions was synthesized and tested for their cytotoxicity against selected human cancer cells. Most of the molecules exhibited significant antiproliferative activity with compound 12 p being the most potent. It exhibited significant cytotoxicity against MCF‐7 breast cancer cells (IC 50 value 3.14±0.50 μM), evidenced by the decrease in viable cells and increased apoptotic features during phase contrast microscopy, such as AO/EB, DAPI and DCFDA staining studies. Compound 12 p also inhibited cell migration in wound healing assay. Anticancer potential of 12 p was proved by the inhibition of tubulin polymerization with IC 50 of 5.64±0.15 μM. These results imply the potential of benzimidazole substituted spirocyclopropyl oxindoles, notably 12 p , as cytotoxic agent for the treatment of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsApoptosisBenzimidazolesCell ProliferationOxindolesTubulin ModulatorsHumansCell Line, TumorCell MovementDose-Response Relationship, DrugDrug DevelopmentDrug Screening Assays, AntitumorMCF-7 CellsMolecular StructurePolymerizationSpiro CompoundsStructure-Activity RelationshipTubulin

Stichwörter der Autor:innen

AnticancerBenzimidazoleSAR (Structure activity relationship)SpirooxindolesTubulin polymerase inhibition

Substanzen

2-oxindoleAntineoplastic AgentsbenzimidazoleBenzimidazolesOxindolesSpiro CompoundsTubulinTubulin Modulators

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Hyderabad, 500037, India.
  • Department of Biological Sciences (Pharmacology & Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Hyderabad, 500037, India.
  • Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Hyderabad, 500078, India.

ORCID-Profile: Nagula Shankaraiah

Zitieren

APA

Sakla, A. P., Bazaz, M. R., Mahale, A., Sharma, P., Valapil, D. G., Kulkarni, O. P., Dandekar, M. P., & Shankaraiah, N. (2024). Development of Benzimidazole‐Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. ChemMedChem. https://doi.org/10.1002/cmdc.202400052

Vancouver

Sakla AP, Bazaz MR, Mahale A, Sharma P, Valapil DG, Kulkarni OP, et al. Development of Benzimidazole‐Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. ChemMedChem. 2024. doi:10.1002/cmdc.202400052

BibTeX
@article{Sakla2024,
  author = {Sakla, Akash P and Bazaz, Mohd Rabi and Mahale, Ashutosh and Sharma, Pravesh and Valapil, Durgesh Gurukkala and Kulkarni, Onkar Prakash and Dandekar, Manoj P and Shankaraiah, Nagula},
  title = {Development of Benzimidazole‐Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400052}
}
Kostenlos starten →